Alesco Advisors’s Pfizer PFE Stock Holding History

Alesco Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-5,617	Closed	-$206K	–	173
2023 Q2	$206K	Hold	5,617	–	–	0.01%	161
2023 Q1	$229K	Buy	5,617 +17	+0.3%	+$734	0.01%	155
2022 Q4	$287K	Sell	5,600 -116	-2%	-$5.56K	0.01%	144
2022 Q3	$250K	Buy	5,716 +1,700	+42%	+$82.6K	0.01%	133
2022 Q2	$211K	Sell	4,016 -30	-0.7%	-$1.53K	0.01%	142
2022 Q1	$209K	Sell	4,046 -204	-5%	-$10.6K	0.01%	143
2021 Q4	$251K	Buy	+4,250	New	+$211K	0.01%	132
2019 Q3	–	Sell	-6,905	Closed	-$284K	–	134
2019 Q2	$284K	Buy	+6,905	New	+$274K	0.02%	116
2017 Q4	–	Sell	-12,683	Closed	-$430K	–	121
2017 Q3	$430K	Buy	12,683 +2,144	+20%	+$68.9K	0.03%	97
2017 Q2	$336K	Sell	10,539 -211	-2%	-$6.65K	0.02%	97
2017 Q1	$349K	Sell	10,750 -5,091	-32%	-$161K	0.02%	100
2016 Q4	$488K	Sell	15,841 -4,179	-21%	-$128K	0.04%	86
2016 Q3	$643K	Buy	20,020 +2,677	+15%	+$89.5K	0.05%	74
2016 Q2	$579K	Hold	17,343	–	–	0.05%	74
2016 Q1	$488K	Sell	17,343 -2,972	-15%	-$84.9K	0.04%	77
2015 Q4	$622K	Sell	20,315 -274	-1%	-$8.62K	0.05%	70
2015 Q3	$614K	Hold	20,589	–	–	0.06%	71
2015 Q2	$655K	Buy	20,589 +3,531	+21%	+$115K	0.06%	72
2015 Q1	$563K	Hold	17,058	–	–	0.05%	72
2014 Q4	$504K	Sell	17,058 -817	-5%	-$23.4K	0.05%	74
2014 Q3	$501K	Buy	17,875 +817	+5%	+$22.9K	0.05%	71
2014 Q2	$480K	Hold	17,058	–	–	0.05%	72
2014 Q1	$520K	Buy	+17,058	New	+$509K	0.05%	66

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Alesco Advisors's PFE Position: Q3 2023 in Review

Alesco Advisors sold out of Pfizer (PFE) in Q3 2023, closing a stake of 5,617 shares — an estimated $206K sold.

Alesco Advisors first reported a position in PFE in Q1 2014 and held it in 23 quarters. The position peaked at $655K in Q2 2015. 2,928 funds tracked by Wall St. Rank hold PFE as of Q3 2023.

Alesco Advisors reported no remaining Pfizer position as of Q3 2023 after selling out during the quarter.
Alesco Advisors sold 5,617 Pfizer shares in Q3 2023, an estimated $206K.
Alesco Advisors first reported a position in Pfizer in Q1 2014 and held it in 23 quarters.
Alesco Advisors's Pfizer position peaked at $655K in Q2 2015.
2,928 funds tracked by Wall St. Rank held Pfizer as of Q3 2023.

Based on Alesco Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.